These innovative medications , Retatrutide, represent a significant advancement in addressing metabolic dysfunction and conceivably associated conditions . They are categorized as GLP-1 hormone agonists , indicating they to emulate the endogenous GLP-1 hormone , stimulating insulin secretion and lowering hunger . Despite Semaglutide each one works